Dog Assisted Therapy Program for Children With ADHD
DOGAD
1 other identifier
interventional
36
1 country
2
Brief Summary
The purpose of this study was to evaluate the efficacy of AAT intervention in children with Attention Deficit Hyperactivity Disorder (ADHD), in terms of improving functionality, ADHD-associated symptoms, attention and working memory. Participants were recruited from a community Child and Adolescent Mental Health Service and a Primary Health Care Center. These objectives were accomplished through a multicenter, randomized clinical trial, open-label, two-arm study of AAT for children with ADHD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2018
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 27, 2023
CompletedFirst Submitted
Initial submission to the registry
July 4, 2024
CompletedFirst Posted
Study publicly available on registry
July 11, 2024
CompletedJuly 15, 2024
July 1, 2024
2 months
July 4, 2024
July 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change from baseline Children's Global Assessment Scale (CGAS) at 14 weeks.
It is a numerical scale to rate the overall functioning of young people under 18 years of age. Scores range from 1 to 100. A higher score indicates better functioning.
This scale was administered at baseline and at week 14
Change from baseline Clinical Global Impression - Severity Scale (CGI-S) at 14 weeks
Is an instrument for measuring symptom severity of patients with mental disorders. Uses a single item on a Likert scale of seven values from 1= "Normal, not at all ill" to 7= "Among the most extremely ill patients".
This scale was administered at baseline and at week 14
Secondary Outcomes (2)
Change from baseline Wechsler Intelligence Scale for Children (WISC-IV) at 14 weeks.
This scale was administered at baseline and at week 14
Change from baseline Conners' Continuous Performance Test 3rd Edition (Conners CPT 3) at 14 weks
This test was administered at baseline and at week 14
Other Outcomes (1)
Change from baseline Conners Rating Scales Revised at 14 weeks.
This scale was administered at baseline and at week 14
Study Arms (2)
Experimental Group
EXPERIMENTALThe experimental group carried out a total of 14 one-hour group sessions, on a weekly basis for 14 consecutive weeks. The groups were formed by 8 participants. Sessions included the participation of one certified therapy dog, one technician specialized in AAT and a psychologist. Participants received their usual treatment (pharmacological and/or individual and family cognitive-behavioral treatment). Intervention: All sessions: Establishment of structured routines and schedules to help the child organize and manage daily responsibilities. Positive reinforcement to reward and motivate desirable behaviors. Sessions 1-7: Impulsivity management techniques. Social skills training. Self-control techniques to identify and manage moments of impulsivity. Sessions 8-14: Reinforcement of attention and concentration through strategies such as dividing tasks into smaller, more manageable parts. Cognitive-behavioral therapy to work on self-esteem, self-control and problem solving.
Control Group
NO INTERVENTIONTreatment as usual (pharmacological and/or individual and family cognitive-behavioral treatment).
Interventions
A structured AAT program and usual treatment in Experimental group.
Eligibility Criteria
You may qualify if:
- Age between 7 and 12 years old (included).
- Diagnosis of ADHD confirmed at the Child and Adolescent Mental Health Service.
- Intelligence quotient of 80 or higher.
- Delivery of the information sheet and signature of the informed consent.
You may not qualify if:
- If in the initial interview they declared having allergy or fear of dogs.
- History of aggression towards animals.
- Co-morbidity with other disorders (conduct disorders, autism spectrum disorders, anxiety disorder or depression).
- If the treatment regimen was modified during the intervention period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Centre Atenció Primària Bordeta-Magraners
Lleida, 25001, Spain
Salut Mental Infanto-Juvenil Sant Joan de Déu Terres de Lleida
Lleida, 25001, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
M. Dolores Rodrigo Claverol, PhD
Institut Català de la Salut
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 4, 2024
First Posted
July 11, 2024
Study Start
December 1, 2018
Primary Completion
February 1, 2019
Study Completion
April 27, 2023
Last Updated
July 15, 2024
Record last verified: 2024-07